Authors:
VANWEISSENBRUCH MM
SCHOEMAKER HC
DREXHAGE HA
SCHOEMAKER J
Citation: Mm. Vanweissenbruch et al., PHARMACODYNAMICS OF HUMAN MENOPAUSAL GONADOTROPIN (HMG) AND FOLLICLE-STIMULATING-HORMONE (FSH) - THE IMPORTANCE OF THE FSH CONCENTRATION ININITIATING FOLLICULAR-GROWTH IN POLYCYSTIC OVARY-LIKE DISEASE, Human reproduction, 8(6), 1993, pp. 813-821
Authors:
SCHEELE F
HOMPES PGA
VANDERMEER M
SCHOUTE E
SCHOEMAKER J
Citation: F. Scheele et al., THE EFFECTS OF A GONADOTROPIN-RELEASING-HORMONE AGONIST ON TREATMENT WITH LOW-DOSE FOLLICLE-STIMULATING-HORMONE IN POLYCYSTIC-OVARY-SYNDROME, Human reproduction, 8(5), 1993, pp. 699-704
Authors:
SCHEELE F
HOMPES PGA
VANDERMEER M
SCHOUTE E
SCHOEMAKER J
Citation: F. Scheele et al., PULSATILE GONADOTROPIN-RELEASING-HORMONE STIMULATION AFTER MEDIUM-TERM PITUITARY SUPPRESSION IN POLYCYSTIC-OVARY-SYNDROME, Human reproduction, 8, 1993, pp. 197-199
Citation: Dj. Hemrika et al., PULSATILE LUTEINIZING-HORMONE PATTERNS IN LONG-TERM ORAL-CONTRACEPTIVE USERS, The Journal of clinical endocrinology and metabolism, 77(2), 1993, pp. 420-426
Authors:
SCHEELE F
HOMPES PGA
VANDERMEER M
SCHOUTE E
SCHOEMAKER J
Citation: F. Scheele et al., THE RELATIONSHIP BETWEEN FOLLICLE-STIMULATING-HORMONE DOSE AND LEVEL AND ITS RELEVANCE FOR OVULATION INDUCTION WITH ADJUVANT GONADOTROPIN-RELEASING HORMONE-AGONIST TREATMENT, Fertility and sterility, 60(4), 1993, pp. 620-625
Citation: Dj. Hemrika et al., PULSATILE LUTEINIZING-HORMONE SECRETION DURING THE 1ST AND THE 4TH CYCLE ON 2 DIFFERENT ORAL-CONTRACEPTIVES CONTAINING GESTODENE, Acta endocrinologica, 129(3), 1993, pp. 229-236